Prevalence of Fabry disease in TIA/stroke cohorts. What defines Fabry disease?

European Journal of Neurology

Volumn 19, Issue 11, 2012, Pages 1383-1384

  Linthorst, G E ^a   Ginsberg, L ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE;

ANHIDROSIS; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; EDITORIAL; ENZYME ACTIVITY; FABRY DISEASE; GENE MUTATION; HEART LEFT VENTRICLE HYPERTROPHY; HEMANGIOKERATOMA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MISSENSE MUTATION; PREVALENCE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK;

FABRY DISEASE; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; STROKE;

EID: 84867703277     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03763.x     Document Type: Editorial

References (8)

1. Ginsberg L. Fabry disease. In: Sharma P, Meschia JF, eds. Neurogenetics of Stroke. London, UK: Springer, 2012: in press.
2. Mehta A, Ricci R, Widmer U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 2004; 34: 236-242.
3. Germain DP, Waldek S, Banikazemi M, et al. Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease. J Am Soc Nephrol 2007; 18: 1547-1557.
4. Nakao S, Takenaka T, Maeda M, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995; 333: 288-293.
5. Linthorst GE, Bouwman MG, Wijburg FA, Aerts JMFG, Poorthuis BJHM, Hollak CEM. Screening for Fabry disease in high-risk populations: a systematic review. J Med Genet 2010; 47: 217-222.
6. Rolfs A, Böttcher T, Zschiesche M, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005; 366: 1794-1796.
7. Marquardt L, Baker R, Segal H, et al. Fabry disease in unselected patients with TIA or stroke: population based study. Eur J Neurol 2012; 19: 1427-1432.
8. Sarikaya H, Yilmaz M, Michael N, Miserez AR, Steinmann B, Baumgartner RW. Zurich Fabry study. Prevalence of Fabry disease in young patients with first cryptogenic ischemic stroke or TIA. Eur J Neurol 2012; 19: 1421-1426.